Home
overview

SMi is pleased to present the return of their 12th annual Paediatric Clinical Trials Conference taking place on 19th – 20th March 2018, London, UK.


Clinical trials in paediatric populations still pose several challenges and often many studies remain un- published*. 10 years on from the introduction of EU Paediatric Investigation Plans (PIPs) there are still many lessons to be learned about the planning and execution of trials which should be tailored around the needs of children.
Recent advancements in immuno- oncology research has led to an increase in clinical trials to treat cancer in children and adolescents. Greater emphasis has also been placed on pain-free administration of drugs in the bid to increase vaccination uptake and access to medicines.


Join us as we discuss current clinical trials and the innovative digital technology being used to improve clinical recruitment and retention as well as improve the quality of data being collected. leading industry experts will be looking at how to work within regulations and foster the involvement of young people in their care. We will also be looking at the planning and executing a paediatric clinical trial and the ways this can vary according to region. We will be exploring the complexities of paediatric drug formulation and helping you determine clinical endpoints.
 

http://bit.ly/2b7KNMy


 

  • Regulatory keynote from the MHRA on The UK's Early Access to Medicines Scheme (EAMS) and how this scheme benefits paediatric patients
  • Hear from Amgen and Roche as they give exclusive case studies on new approaches to recruitment, retention, and clinical trial design for rare diseases
  • Pfizer and Barcelona Children’s Hospital will be exploring how advancements in technology are facilitating improved clinical trials and data collection for paediatric drug development
  • AstraZeneca will be reviewing and discussing paediatric clinical trial Legislation in the EU and US.
  • There will be an exciting panel with the likes of GSK, Roche and regulatory bodies debating challenges and opportunities 10 years on from paediatric regulation in the EU and potential changes on the horizon
  • There will be multiple pharmaceutical companies (UCB, Sanofi and GSK) debating scenarios where data extrapolation and government incentives might increase access to medicines in paediatric populations
  • Discover how to optimise your approach to clinical success through global collaboration being discussed by Takeda

 

Directors, Chiefs, VPs, Heads, Managers, Principals of:

- Clinical Trials/ Paediatric
- Clinical Research
- Medical Officer
- Regulatory Affairs
- Clinical Operations
- (Paediatric) Drug Development
- Drug Formulation
- Medical devices
 

Alexion Pharmaceuticals; Apeiron Biologics AG; Astrazeneca; Austrian Agency for Health and Food Safety; Baxter BioPharmaceuticals; Birmingham Children's Hospital; EURODIS; Genencor International; GSK; Hoffmann-La Roche Limited; Insys Therapeutics, Inc.; Johnson & Johnson; Kiadis Pharma; KinderPharm; klausrose Consulting; mayer brown llp; MHRA; Novo Nordisk; Novo Nordisk AS; Orchard Therapeutics; Otsuka Europe Development and Commercialisation Ltd; Paediatric Research Consultancy; PHARMALEX GmbH; Proveca; Roche Products Ltd; tesa Labtec GmbH; The Doctors Laboratory Limited; The Royal Children's Hospital Melbourne; UCB Biosciences GmbH; University Hospital Ghent; Zeincro Hellas S.A.;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Mark  Turner

Mark Turner, Chair, European Network of Paediatric Research at the European Medicines Agency and Senior Lecturer in Neonatal Medicine, University of Liverpool

9:10 Live attenuated influenza vaccination in children

Maria Zambon

Maria Zambon, Deputy Director National Infection Service, Public Health England

• Experience of live attenuated influenza vaccine (LAIV) introduction in the UK
• Challenges and successes
• Improving strain selection
• Discussion of unanswered scientific questions

9:50 Paediatric trial design and modeling: Moving into the next decade - industry approach to innovative paediatric trial design

Claudio Fracasso

Claudio Fracasso, Global Pediatric Medical Director, Pfizer
View Bio

• What is industry doing to improve paediatric clinical trial innovation (infrastructure, patient engagement, collaboration)
• Innovative study design and solutions
• Call for actions
 

10:30 Morning Coffee

11:00 New methodological tools for Paediatric extrapolation

Bernard Sebastien

Bernard Sebastien, Pharmacometrician Clinical Trial Simulation, Sanofi
View Bio

• Various levels of Paediatric extrapolation
• Bayesian approach for Paediatric extrapolation
• Paediatric extrapolation of adult Exposure-response relationships
• Paediatric extrapolation of adult efficacy data

11:40 Model informed Drug discovery and development (MID3) and extrapolation in Paediatric trials

Amy  Cheung

Amy Cheung, Senior Clinical Pharmacometrician, Project Manager, Paediatric Working Group, AstraZeneca

• Overview of MID3: What are the benefits?
• Regulatory expectations
• Case examples using MID3 framework
 

12:20 Networking Lunch

13:30 Extrapolation in paediatric development: A case in partial onset seizures

Jan-Peer Elshoff

Jan-Peer Elshoff, Associate Clinical Program Director, UCB Pharma

• PBPK to estimate dosing in first paediatric study
• Population PK to adapt dose recommendations and predict IV dosing
• Support of dose selection by PK-PD using adult data and data from a second compound

14:10 Optimising recruitment by ensuring family friendly information for paediatric

Jane Lamprill

Jane Lamprill, Paediatric Research Consultant Specialist Medical Writer for Children and Member FP7 Ethics Panel, Paediatric Research Consultancy
View Bio

Optimising recruitment by ensuring family friendly information for paediatric clinical trials
• The challenges of paediatric study information provision
• Brief overview legal and ethical framework
• Top tips to avoid ethics committee pitfalls
• Brief overview of consent assent and dissent
• Information considerations for parents
• Information considerations for different age children
 

14:50 Patient involvement in paediatric research and medicines development

Joana Claverol

Joana Claverol, Clinical Research Unit Manager, Barcelona Children’s Hospital

• The voice of children in research: The European YPAG (Young Persons’ Advisory Group) network
• Collaborative research with the involvement of parents of children with rare disease
• Rare commons and Share4Rare platform

15:30 Afternoon Tea

16:00 European collaboration on paediatric research and regulation

Mark  Turner

Mark Turner, Chair, European Network of Paediatric Research at the European Medicines Agency and Senior Lecturer in Neonatal Medicine, University of Liverpool

• Patient recruitment across borders and the current state of European Networks
• How might Brexit impact the development and approval of new medicines will be regulated in the UK and are PIPs still likely to apply?
• What are the funding options for paediatric clinical research in the UK and the rest of Europe?
• Ensuring children have access to new medicines
 

16:40 Paediatric medicine regulation in the EU: What are the challenges and opportunities 10 years on?

• What effect have PIPs (paediatric investigation plans) had on the quality of the paediatric clinical trials and has this translated into greater efficiency in access to new approved medicines?
• What are future changes/limitations to paediatric research?
• Should extrapolation be the norm?
• How can these challenges be overcome now and in the future?

Sabine Fuerst-Recktenwald

Sabine Fuerst-Recktenwald, Senior Medical Director Pediatric Oncology, Roche

Daren Austin

Daren Austin, Senior Fellow and Senior Director, Clinical Pharmacology, GSK

Mark  Turner

Mark Turner, Chair, European Network of Paediatric Research at the European Medicines Agency and Senior Lecturer in Neonatal Medicine, University of Liverpool

17:20 Chairman’s Closing Remarks and Close of Day One

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Philippe  Auby

Philippe Auby, CEO & President, OEDC, Otsuka Europe Development and Commercialisation Ltd
View Bio

9:10 Preparing for clinical trials in paediatric rare diseases

Meghan Thorne-Miller

Meghan Thorne-Miller, Project Leader and Discovery Scientist, Rare Diseases, Roche
View Bio

• Understanding the disease and patient population
• Adopting a patient centric approach. Importance of the patient/caregiver perspective
• Selecting relevant outcome measures
• Early engagement with regulatory authorities

9:50 Extrapolation in severe eosinophilic asthma: case studies using partial and full extrapolation approaches

• Regulatory background and interactions
 

Caroline Townsend

Caroline Townsend, Global Regulatory Affairs, Respiratory, GSK
View Bio

Daren Austin

Daren Austin, Senior Fellow and Senior Director, Clinical Pharmacology, GSK

10:30 Morning Coffee

11:00 Development plan and phase 2 data of the bi – specific T cell engager (BiTE) blinatumomab in paediatric B – precursor acute lymphoblastic leukemia (ALL)

Gerhard 	 Zugmaier

Gerhard Zugmaier, Executive Medical Director Global Development, Amgen
View Bio

• Mechanism of action
• Development program
• Efficacy in paediatric ALL
• Changes in laboratory parameters
• Summary
 

11:40 Advances in paediatric formulation development: Baby steps

Trupti Dixit

Trupti Dixit, Director, Strategy and Operations, Takeda
View Bio

• What are the “Expectations” versus “Reality”?
• What approaches can be taken to bridge the gap in formulation development
• Conclusions
 

12:20 Networking Lunch

13:30 The UKs Early Access to Medicines Scheme (EAMS) – How can the scheme benefit paediatric patients?

Dominik Karres

Dominik Karres, Medical Assessor, Biologicals Unit, LD, MHRA
View Bio

• The Promising Innovate Medicines (PIM) designation and the scientific opinion – what is the procedure and how does it work?
• How to weigh the risks and the benefits in cases of small numbers
• Real life examples
 

14:10 Paediatric drug development and multiregional regulatory considerations

Solange Rohou

Solange Rohou, Senior Director Regulatory Affairs and Policy , AstraZeneca

• Global paediatric collaboration and how paediatric drug development differs according to countries
• Paediatric research initiatives and networks: Exploring how these can improve drug development
• Developing a common scientific approach to enable effective patient access to approved medicines
 
 

14:50 Afternoon Tea

15:20 Early phase clinical trials in children: How paediatric pharmacology can help?

Dan Hawcutt

Dan Hawcutt, Senior Lecturer Paediatric Clinical Pharmacology, The Royal Liverpool Children's Hospital trust
View Bio

• Developing a deliverable protocol
• Adapting risks and benefits to needs of children and parents
• Delivering the study safely, and to time and target
• Capacity building within the specialty: developments in paediatric pharmacology training in the UK including the addition of early phase clinical trial experience and Faculty of Pharmaceutical medicine collaboration
 

16:00 Directions in therapeutic vaccination in children

David  McIntosh

David McIntosh, Honorary Clinical Senior Lecturer , Imperial College London

• How can successes in adult therapeutic vaccination be translated to children?
• What therapeutic areas in children may benefit from this approach?
• The immune systems of adults and children: similarities and differences
• What are the sorts of clinical trials that need to be performed in children?
 

16:40 Advanced therapy medical products (ATMPs) in Children

Robb Kahn

Robb Kahn, Drug Safety Consultant Clinical Development, Kite Pharma

• The status of development of cell and gene therapies in the EU
• The path to translation outside of the academic realm and into licensed, marketable medicines.
• Discussion of CAR T therapy for children with ALL as a model for ATMPs in paediatrics
 

17:20 Chairman’s Closing Remarks and Close of Day Two

+

FEATURED SPEAKERS

Bernard Sebastien

Bernard Sebastien

Pharmacometrician Clinical Trial Simulation, Sanofi
Caroline Townsend

Caroline Townsend

Global Regulatory Affairs, Respiratory, GSK
Claudio Fracasso

Claudio Fracasso

Global Pediatric Medical Director, Pfizer
Dan Hawcutt

Dan Hawcutt

Senior Lecturer Paediatric Clinical Pharmacology, The Royal Liverpool Children's Hospital trust
Mark  Turner

Mark Turner

Chair, European Network of Paediatric Research at the European Medicines Agency and Senior Lecturer in Neonatal Medicine, University of Liverpool
Meghan Thorne-Miller

Meghan Thorne-Miller

Project Leader and Discovery Scientist, Rare Diseases, Roche
Solange Rohou

Solange Rohou

Senior Director Regulatory Affairs and Policy , AstraZeneca
Trupti Dixit

Trupti Dixit

Director, Strategy and Operations, Takeda

Amy Cheung

Senior Clinical Pharmacometrician, Project Manager, Paediatric Working Group, AstraZeneca
Amy  Cheung

Bernard Sebastien

Pharmacometrician Clinical Trial Simulation, Sanofi
Bernard Sebastien

After a PhD in statistics Bernard Sebastien worked in phase 2/phase 3 drug development, as project statistician, at Synthelabo, and then Sanofi. In 2006, he worked in early development/clinical pharmacology Biostatistics still in Sanofi. Since 2010 Bernard has been fully dedicated to Modelling and Simulation activities in Sanofi.

Caroline Townsend

Global Regulatory Affairs, Respiratory, GSK
Caroline Townsend

Caroline Townsend began her career in pharmacovigilance before moving to Global Regulatory Affairs at GlaxoSmithKline. Since then she has provided regulatory support to a broad range of products in various therapeutic areas. Currently she is working in the Respiratory area at GSK providing regulatory support to a product with multiple indications and associated paediatric investigation plans.

Claudio Fracasso

Global Pediatric Medical Director, Pfizer
Claudio Fracasso

Claudio Fracasso graduated as a Medical Doctor at the University of Bari, Apulia, Italy, where he also completed his specialization in Infectious Diseases, and got the certification for medical practice. Since early ‘90s he has been involved in basic and clinical research, with focus on clinical management and therapy of HIV-infected subjects, at the Clinic of Infectious Diseases of Bari, and then for a few years at the Microbiology and Tumorbiology Center of the Karolinska Institute in Stockholm, Sweden.
In 1997 he was appointed Senior Researcher at the Superior Institute of Health in Rome, Italy, the research body of the Ministry of Health, for the setup of the preclinical evaluation of a candidate anti-HIV vaccine, currently in clinical evaluation.
In 1999 he joined Wyeth in the CR&D department being responsible for the medical oversight of clinical trials conducted in several Mediterranean countries, with close attention to those involving vulnerable populations. In this role he followed several phase 1 to 3 pediatric trials in different therapeutic areas, developing new tools specific for children.
In 2010, Claudio joined Pfizer as Regional Clinical Development Director, being responsible of the scientific integrity and medical oversight of clinical trials, and he was almost fully dedicated to children’s clinical studies, working very closely with the most important children’s hospitals in South Western Europe, becoming a reference point in Europe for the Pfizer Pediatric Center of Excellence, that he joined in 2016 as Global Pediatric Medical Director.
He is collaborating with several organizations outside Pfizer, including the Children’s Working Party at the European Forum for Good Clinical Practice, the Children Research Industry Group in UK, the IMI-2 Call 10 Sponsor Consortium, and he is making available his experience in the creation and growth of children’s advocacy groups in Italy and Europe. Claudio is lecturer at the Master on Clinical Research at the Catholic University of Rome. 
 

Dan Hawcutt

Senior Lecturer Paediatric Clinical Pharmacology, The Royal Liverpool Children's Hospital trust
Dan Hawcutt

Dan Hawcutt is a paediatric pharmacologist working at the University of Liverpool and Alder Hey Children’s hospital. He graduated from the University of Liverpool, before working in Nottingham and Oxford, and returning to Liverpool. He has research interests in pharmacogenomics (precision dosing, and genomic risk factors for adverse drug reactions in children), early phase clinical trials (antimicrobials, cystic fibrosis), and pharmacovigilance (including hard to access paediatric populations). He is clinical lead for the NIHR Alder Hey clinical trials unit, a specialist paediatric early phase trials unit based within Alder Hey, and is chair of the Alder Hey drugs and therapeutics committee, and a member of the Royal College of Paediatrics and Child Health Medicines Committee. He also supervises the clinical and academic training of junior doctors in Paediatric Clinical Pharmacology and Therapeutics.

Daren Austin

Senior Fellow and Senior Director, Clinical Pharmacology, GSK
Daren Austin

David McIntosh

Honorary Clinical Senior Lecturer , Imperial College London
David  McIntosh

Dominik Karres

Medical Assessor, Biologicals Unit, LD, MHRA
Dominik Karres

Dominik’s clinical background is in Paediatrics with special interest in paediatric oncology. He worked in Germany and the UK, last as a clinical research fellow in paediatric oncology drug development at the Royal Marsden Hospital. He as an MD in paediatric drug development and published several book chapters and articles in Peer-reviewed journals on the topics of therapeutic drug monitoring and drug development in children. Since beginning of 2014 he works as a medical assessor at the MHRA, now in the Biologicals Unit of the Licensing Division.

Gerhard Zugmaier

Executive Medical Director Global Development, Amgen
Gerhard 	 Zugmaier

Gerhard Zugmaier is a board certified hematologist and oncologist and full member of the faculty of medicine at the University of Marburg, where he teaches internal medicine. There he had been in charge of the Bone Marrow Transplantation Unit and the Outpatient Clinic. He then joined Roche in 2003 as a Clinical Scientist and was mostly responsible for the design of phase 2 trials of Pertuzumab in ovarian cancer, lung cancer and breast cancer there. Starting in March 2006 he has worked at Micromet AG, which was changed to Amgen Research (Munich) GmbH in March 2012. Gerhard Zugmaier is responsible for the development program of blinatumomab in acute lymphocytic leukemia. He is author of publications in high rank Journals including Science, Leukemia, Haematologica, Lancet Oncology, Journal of Clinical Oncology and Blood.

Jane Lamprill

Paediatric Research Consultant Specialist Medical Writer for Children and Member FP7 Ethics Panel, Paediatric Research Consultancy
Jane Lamprill

Paediatric Research ConsultancyTM (PRC) based near London was founded in 2004 by Jane Lamprill RN RSCN FICR. Jane trained as a sick children’s nurse at Great Ormond Street Hospital for Children. She was Senior Research Sister/SSC for 17 years organising and performing industry and academic paediatric trials & was Paediatric Research Advisor for Origin Pharmaceutical Services. Since 2008 Jane has been an ethics expert for the European Commission, reviewing research grant applications with e.g. European Research Council. Her advice and family friendly information & artwork have helped clients significantly improve recruitment and compliance. She provides protocol feasibility reports for practical, ethical and operational issues which have helped smooth ethics committee/IRB reviews. Jane has just launched another PRC called Please Read CarefullyTM. This will focus on lay language communications for EMA Layperson clinical trial summaries. www.janelamp.co.uk and www.laylanguage.com

Jan-Peer Elshoff

Associate Clinical Program Director, UCB Pharma
Jan-Peer Elshoff

Joana Claverol

Clinical Research Unit Manager, Barcelona Children’s Hospital
Joana Claverol

Maria Zambon

Deputy Director National Infection Service, Public Health England
Maria Zambon

Mark Turner

Chair, European Network of Paediatric Research at the European Medicines Agency and Senior Lecturer in Neonatal Medicine, University of Liverpool
Mark  Turner

Meghan Thorne-Miller

Project Leader and Discovery Scientist, Rare Diseases, Roche
Meghan Thorne-Miller

Meghan is a Discovery Project Leader in the Rare Diseases group at Roche in Basel, Switzerland. Bridging the interface between pre-clinical development and clinical translation, her work focuses on bringing the science and patient perspective to clinical trial design.
Meghan earned her PhD in Biomedical Sciences from the department of Pharmacology at the University of California, San Diego in 2010. Joining Roche in 2012, she first worked as a postdoc in the Neuroscience department before joining the Rare Diseases group in 2015.
 

Philippe Auby

CEO & President, OEDC, Otsuka Europe Development and Commercialisation Ltd
Philippe  Auby

Philippe Auby is an Adult, Child and Adolescent Psychiatrist. He received his MD from Toulouse University of Medicine, France. In 1989 and 1990, he worked as a psychiatrist in South East Refugee Camps in Thailand.
After his board certification in adult psychiatry, he completed a board certification in child and adolescent psychiatry.
In 1996, he joined a CRO in Paris before moving to Eli Lilly and BMS. In 2001, he moved to BMS European Headquarter in Belgium prior working for Otsuka America working on paediatric development. Early 2007, he moved to Lundbeck to lead paediatric clinical development until 2016 and was Vice President of Clinical Development, Paediatrics. He is currently CEO & President of Otsuka Europe Development and Commercialisation.

 

Robb Kahn

Drug Safety Consultant Clinical Development, Kite Pharma
Robb Kahn

Sabine Fuerst-Recktenwald

Senior Medical Director Pediatric Oncology, Roche
Sabine Fuerst-Recktenwald

Solange Rohou

Senior Director Regulatory Affairs and Policy , AstraZeneca
Solange Rohou

Trupti Dixit

Director, Strategy and Operations, Takeda
Trupti Dixit

Trupti Dixit is currently a Director at Takeda Development Centers of America, Deerfield, US and a member of the IQ (Innovation and Quality in Pharmaceutical Development) consortium’s Drug Product Leadership Group (DPLG) and a past co-chair of its Pediatric Working group.
Dr. Dixit has a pharmacist degree from University department of Chemical Technology, Bombay, India and a PhD in Pharmaceutical Sciences from University of Kentucky, Lexington, Kentucky, USA. She has since spent more than 23 years in the pharmaceutical industry in the area of CMC development and has contributed to several globally marketed pharmaceutical products and numerous development programs. Her expertise is in supporting CMC development from preclinical to approval phase of new chemical entities. Her special interest lies in the area of pediatric product development. As a Co-chair of pediatric working group she was involved in planning and executing a workshop titled “Challenges and Strategies to Facilitate Formulation Development of Pediatric Drug Products” held at College Park, MD June 8-9 2016. She has been invited in the past to present at the EuPFI annual meetings in 2014, 2016 and has also presented in the GRiP webinar series on IQ’s pediatric formulation development survey outcomes in January 2015.
 

Official Publication

Supporters

Workshops

Paediatric regulation: From PIP to rewards
Workshop

Paediatric regulation: From PIP to rewards

Copthorne Tara Hotel
21st March 2018
London, United Kingdom

VENUE

Copthorne Tara Hotel

Scarsdale Place, Kensington, London, United Kingdom

The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

 

HOTEL BOOKING FORM

Media Partners


International Journal of Services and Standards

Official Publication
http://www.inderscience.com/ijss

IJSS presents current practice, models, and theory in both services and standards development, design, management, implementation, and applications. Its objectives are to develop, promote and coordinate the development and practice in services and standards.


International Journal of Healthcare Policy

Official Publication
http://www.inderscience.com/ijhp

IJHP serves as a forum for interdisciplinary discussion of leading issues in healthcare law, medicine and health policy. Emphasis is placed on issues such as legislative and regulatory environments, and plans and actions that are undertaken by organisations and agencies to achieve specific healthcare goals within society. This perspective is reflective of the broad range of efforts to advance the public's health.


International Journal of Technology, Policy and Management

Official Publication
http://www.inderscience.com/ijtpm

IJTPM is a refereed international journal that provides a professional and scholarly forum in the emerging field of decision making and problem solving in the integrated area of technology policy and management at the operational, organisational and public policy levels.


International Journal of Healthcare Technology and Management

Official Publication
http://www.inderscience.com/ijhtm

IJHTM is a series emerging from the International Journal of Technology Management. It provides an international forum and refereed authoritative sources of information in the fields of the economics and management of technology in healthcare.


International Journal of Biomedical Engineering and Technology

Official Publication
http://www.inderscience.com/ijbet

IJBET addresses cutting-edge research in the multi-disciplinary area of biomedical engineering and technology. Medical science incorporates scientific/technological advances combining to produce more accurate diagnoses, effective treatments with fewer side effects, and improved ability to prevent disease and provide superior-quality healthcare. A key field here is biomedical engineering/technology, offering a synthesis of physical, chemical, mathematical and computational sciences combined with engineering principles to enhance R&D in biology, medicine, behaviour, and health. IJBET includes the Asia-Pacific Chapter in Biomedical Wireless Technology (APC-BWT).

Media Partners


Pharmaceutical-Review

Supporters
http://www.pharmaceutical-review.com

Pharmaceutical-review.com is part of Integrated IQ technologies Private Limited(IIQ). A Leading platform for all the Pharma manufacturing companies and buyers across the world.Having a subscriber database of more than 120,000 globally helping the clients to reach their target buyers through our exclusive listing, branding(banner advertisement), e-news letters, e-mail marketing, product reviews, product launch promotions, event marketing, search engine marketing and social media marketing services.


European Biotechnology Network

Supporters
http://european-biotechnology.net/

The European Biotechnology Network is dedicated to facilitating co-operation between professionals in biotechnology and the life sciences all over Europe. The non-profit organisation brings research groups, universities, SMEs, large companies and indeed all actors in biotechnology together to build and deliver partnerships.


Drug Target Review

Supporters
http://www.drugtargetreview.com

Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


Swiss Biotech Association

Supporters
http://www.swissbiotech.org/

The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


Labsave

Supporters
http://www.labsave.com

Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


Inderscience Publishers

Supporters
http://www.inderscience.com

Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


Biosave

Supporters
http://www.Biosave.com

Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


SciDoc Publishers

Supporters
http://www.scidoc.org

SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals - Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications - online.


Pharmalicensing

Supporters
http://www.pharmalicensing.com

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


Pharmavision

Supporters
http://www.pharmavision.co.uk

PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


ASD MEDIA

Supporters
http://www.asd-network.com

Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
  • Be informed on the latest market developments; www.asd-network.com
  • Find the latest business news; www.asd-network.com
  • Find the upcoming events; www.asd-network.com
  • Find companies and organizations; www.asdsource.com
  • Distribute news globally. www.asdwire.com
The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

For more detailed information please contact with: ASD MEDIA
Stefan.koopman@asdmedia.nl


PharmaVOICE

Supporters
http://www.pharmavoice.com

PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


Drug Development Technology

Supporters
http://www.drugdevelopment-technology.com

Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


CanBiotech

Supporters
http://www.canbiotech.com

CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


Samedan

Supporters
http://www.samedanltd.com/magazine/13.

International Clinical Trials (ICT) is a quarterly magazine edited by Dr Graham Hughes, and written by specialists at the forefront of clinical research. ICT’s coverage of operational developments ranges from adaptive designs in early phase trials through to post marketing research. ICT’s targeted readership consists of key decision makers across the pharmaceutical and biotech industries, along with contract partners and consultants. The magazine is distributed to pharmaceutical professionals in Europe and North America, and is accessed globally online. Read the latest issues, explore the ICT archive and subscribe at www.samedanltd.com/magazine/13.


Medical News Today

Supporters
http://www.medicalnewstoday.com

Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.


Gate2Biotech

Supporters
http://www.gate2biotech.com

Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


Bentham Science

Supporters
http://www.benthamscience.com/

Bentham Science Publishers is a major STM journal publisher of 116 titles and 200 plus open access journals and print/online book series (Bentham eBooks). Bentham Science answers the information needs of the pharmaceutical and biomedical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.113) and Current Medicinal Chemistry (Impact Factor 4.859): FREE online journals and information: www.benthamscience.com


Journal for Clinical Studies – Your Resource for Multisite Studies & Emerging Markets

Supporters
http://www.JforCS.com

Published bi-monthly.JCS is a unique journal, dedicated to providing information to the global pharmaceutical, biotechnology, medical devices and contract research organisations. JCS details practical and theoretical operational procedures, challenges, validatory and regulatory guidelines when conducting trials on a multisite basis and particularly within the emerging markets, naïve patient population, and remote access areas. JCS provides country by country objectives and uniquely brings you experiences in therapeutic areas of Liver diseases, kidney diseases, insect borne diseases, malnutrition and under nutrition. JCS is led by a strong editorial advisory board sourced out for their experiences; you will get the most practical insight for your global studies. JCS invites you to join us, write for us, feature your experiences with us, advertise your capabilities with us, and ask our advisory board for suggestions and guidelines. Let us make health care available to all.


Mednous

Supporters
http://www.MedNous.com

MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


Technology Networks

Supporters
http://www.technologynetworks.com

Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


Absave

Supporters
http://www.absave.com

Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


Select Science

Supporters
http://www.selectscience.net/

SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


Contract Biotechnology

Supporters
http://www.contract-biotechnology.com

Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. We are an online R&D matching tool that connects Scientifics and organizations involved in discovery, development and delivery of new healthcare products with service and products providers worldwide. Life science information technology is undergoing a revolution. Part of that revolution involves new, unexplored business models, open innovation, open data and collaboration. If you have a project or idea that you would like to propose, develop or run, we can help. A New Collaboration Network Model for Discovery Research and Development • Effective Platform: the 95% • 5.000 registered users // > 15.000 Newsletter subscribers • Geographical background: 45,5% Europe / 37,5% North America / 16,5% Asia / 0,5% ROW • Professional background: Outsourcing Manager, Project Manager, CEO, Business Developer, CSO, Account Manager, Sales & Marketing People, Scientists, R&D. For further information, please visit our website www.contract-biotechnology.com


Pharmacircle

Supporters
http://www.pharmacircle.com

PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


Copybook - Pharmaceutical

Supporters
http://www.copybook.com/pharmaceutical

Copybook is a global business network with many pharmaceutical events, exhibitions and seminars. We encourage business-to-business transactions and work tirelessly to gain our customers new business contracts worldwide. You can add events, companies and associations for free. When you are a member, you can add your company to the events listed in order to encourage other visitors to arrange meetings and appointments at those events to facilitate new business contracts. Want to see how we can increase your business network and transactions? SIGN UP FOR FREE today! Copybook – Your Global Business Network

SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

Copthorne Tara Hotel

Scarsdale Place
Kensington
London W8 5SR
United Kingdom

Copthorne Tara Hotel

The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

 

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SMi GROUP LTD

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71




Forgotten Password

Please enter the email address you registered with. We will email you a new password.